Jens Lindberg
Vermögen: 122 030 $ am 30.06.2026
Vermögen: 122 030 $ am 30.06.2026
Jens Lindberg currently works at Medivir AB, as Chief Executive Officer from 2022 and BrainCool AB, as Chairman from 2024.
Mr. Lindberg also formerly worked at AstraZeneca A, as Director-Investor Relations from 2013 to 2014 and Sedana Medical AB, as Vice President-Commercial Operations from 2021 to 2022.
Mr. Lindberg received his undergraduate degree from Millersville University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDIVIR AB 0,12 % | 05.03.2026 | 668.000 ( 0,12 % ) | 122 030 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDIVIR AB | Vorstandsvorsitzender | 24.01.2022 |
| BRAINCOOL AB | Vorsitzender | 03.12.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| SEDANA MEDICAL AB | Vorstandsvorsitzender | 01.09.2021 |
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Investor Relations Kontakt | 01.10.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Millersville University
Millersville University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca A/S (Denmark)
AstraZeneca A/S (Denmark) Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical medicines | Health Technology |
BrainCool AB
BrainCool AB Medical SpecialtiesHealth Technology Engages in the research, development, and marketing of medical cooling products | Health Technology |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen